67 research outputs found

    Faire cohabiter mixité et espace public : un enjeu de la revitalisation urbaine. Défis du nouveau Saint-Roch à Québec

    Get PDF
    Un des enjeux de la revitalisation urbaine est le rĂ©amĂ©nagement des espaces publics. Parmi les termes rĂ©currents dans les discours des acteurs impliquĂ©s dans le processus de revitalisation du quartier Saint-Roch Ă  QuĂ©bec, nous trouvons celui de mixitĂ©. Ces acteurs souhaitent une revitalisation urbaine prĂ©servant la mixitĂ©. L’examen de leurs discours rĂ©vĂšle la variĂ©tĂ© des reprĂ©sentations de la mixitĂ©, les stratĂ©gies mises en place par les uns et par les autres pour vivre avec ou malgrĂ© la mixitĂ© du quartier ainsi que les conflits visibles ou sous-jacents dĂ©coulant du partage de l’espace public. Pour effectuer cette recherche, nous avons eu recours Ă  des mĂ©moires et des rapports de consultations publiques, Ă  des entretiens semi-dirigĂ©s et Ă  l’observation directe.One of the issues affecting urban renewal is the redevelopment of public space. One of the terms that occur regularly in the discourse of the actors involved in this process is social mix. Apparently, these actors would like to see a policy of urban renewal that perpetuates this social mix. Our analysis of the discourse typical of all those actors participating in the revitalization of the Saint-Roch neighbourhood of Quebec City uncovers a diversity of interpretations of what social mix actually is, and includes strategies for living alongside or despite the social mix characteristic of the neighbourhood, as well as visible or invisible examples of the conflict generated by the sharing of the public space. In the course of our research into this subject, we consulted memoirs and public consultation reports, hosted semi-open interviews and used direct observation

    Housing the low-income elderly in Geneva. A case study (Switzerland)

    Get PDF
    In Geneva (Switzerland), some of the elderly live in housing built especially for this category of the population. Most of this housing is located in the city centre, is close to all services, and has good access to public transportation. However, we observe spatial and social segregation between the elderly who live in retirement housing and the population of their neighbourhood. The aims of this research are to examine the barriers and meeting-points between the elderly who live in these apartments and the population of their neighbourhood, to identify the factors that lead these elderly to be segregated, and to understand how these factors interact. For example, this research indicates that factors such as architectural barriers, difficulty in adapting oneself to new situations, and moving to retirement housing significantly contribute to segregation of people who live in retirement housing. To collect data, a multi-method research approach was used: archival methods (retirement housing\u27s guides), direct observation (retirement buildings and their neighbourhood), and open-ended interviews (staff and residents of retirement housing)

    Trend analysis of imported malaria in London; observational study 2000 to 2014.

    Get PDF
    BACKGROUND: We describe trends of malaria in London (2000-2014) in order to identify preventive opportunities and we estimated the cost of malaria admissions (2009/2010-2014/2015). METHODS: We identified all cases of malaria, resident in London, reported to the reference laboratory and obtained hospital admissions from Hospital Episode Statistics. RESULTS: The rate of malaria decreased (19.4[2001]-9.1[2014] per 100,000). Males were over-represented (62%). Cases in older age groups increased overtime. The rate was highest amongst people of Black African ethnicity followed by Indian, Pakistani, Bangladeshi ethnicities combined (103.3 and 5.5 per 100,000, respectively). The primary reason for travel was visiting friends and relatives (VFR) in their country of origin (69%), mostly sub-Saharan Africa (92%). The proportion of cases in VFRs increased (32%[2000]-50%[2014]) and those taking chemoprophylaxis decreased (36%[2000]-14%[2014]). The overall case fatality rate was 0.3%. We estimated the average healthcare cost of malaria admissions to be just over ÂŁ1 million per year. CONCLUSION: Our study highlighted that people of Black African ethnicity, travelling to sub-Saharan Africa to visit friends and relatives in their country of origin remain the most affected with also a decline in chemoprophylaxis use. Malaria awareness should focus on this group in order to have the biggest impact but may require new approaches

    Tracking of fatness during childhood, adolescence and young adulthood: a 7-year follow-up study in Madeira Island, Portugal

    Get PDF
    Aims: Investigating tracking of fatness from childhood to adolescence, early adolescence to young adulthood and late adolescence to young adulthood. Subjects and methods: Participants from the Madeira Growth Study were followed during an average period of 7.2 years. Height, body mass, skin-folds and circumferences were measured, nine health- and performance-related tests were administered and the Baecke questionnaire was used to assess physical activity. Skeletal maturity was estimated using the TW3 method. Results: The prevalence of overweight plus obesity ranged from 8.2–20.0% at baseline and from 20.4–40.0% at followup, in boys. Corresponding percentages for girls were 10.6– 12.0% and 13.2–18.0%. Inter-age correlations for fatness indicators ranged from 0.43–0.77. BMI, waist circumference and sum of skin-folds at 8, 12 and 16-years old were the main predictors of these variables at 15, 19 and 23-years old, respectively. Strength, muscular endurance and aerobic ïŹtness were negatively related to body fatness. Physical activity and maturation were independently associated with adolescent (15 years) and young adult (19 years) fatness. Conclusions: Over 7.2 years, tracking was moderate-to-high for fatness. Variance was explained by fatness indicators and to a small extent by physical ïŹtness, physical activity and maturation

    Ethical issues at the interface of clinical care and research practice in pediatric oncology: a narrative review of parents' and physicians' experiences

    Get PDF
    Contains fulltext : 97879.pdf (publisher's version ) (Open Access)BACKGROUND: Pediatric oncology has a strong research culture. Most pediatric oncologists are investigators, involved in clinical care as well as research. As a result, a remarkable proportion of children with cancer enrolls in a trial during treatment. This paper discusses the ethical consequences of the unprecedented integration of research and care in pediatric oncology from the perspective of parents and physicians. METHODOLOGY: An empirical ethical approach, combining (1) a narrative review of (primarily) qualitative studies on parents' and physicians' experiences of the pediatric oncology research practice, and (2) comparison of these experiences with existing theoretical ethical concepts about (pediatric) research. The use of empirical evidence enriches these concepts by taking into account the peculiarities that ethical challenges pose in practice. RESULTS: Analysis of the 22 studies reviewed revealed that the integration of research and care has consequences for the informed consent process, the promotion of the child's best interests, and the role of the physician (doctor vs. scientist). True consent to research is difficult to achieve due to the complexity of research protocols, emotional stress and parents' dependency on their child's physician. Parents' role is to promote their child's best interests, also when they are asked to consider enrolling their child in a trial. Parents are almost never in equipoise on trial participation, which leaves them with the agonizing situation of wanting to do what is best for their child, while being fearful of making the wrong decision. Furthermore, a therapeutic misconception endangers correct assessment of participation, making parents inaccurately attribute therapeutic intent to research procedures. Physicians prefer the perspective of a therapist over a researcher. Consequently they may truly believe that in the research setting they promote the child's best interests, which maintains the existence of a therapeutic misconception between them and parents. CONCLUSION: Due to the integration of research and care, their different ethical perspectives become intertwined in the daily practice of pediatric oncology. Increasing awareness of what this means for the communication between parents and physicians is essential. Future research should focus on efforts that overcome the problems that the synchronicity of research and care evokes

    Analyse Transactionnelle Suisse romande – Recueil d'articles 2020

    Get PDF
    Articles diffusĂ©s par l'Association Suisse d’Analyse Transactionnelle – Suisse romande durant l'annĂ©e 2020. Articles - Qu’est ce que l’AT apporte au monde ? - Enseignement spĂ©cialisĂ© et AT – Entrevue - Conseil pĂ©dagogique et AT – Entrevue - L’accouchement-marathon - Les enjeux relationnels de la coopĂ©ration - Les Ă©tapes de la coopĂ©ration - La fosse de rösti – une mine d’or pour des expĂ©riences sur la diversitĂ© -La complexitĂ© par la diversitĂ© – Quelle signification pour la gestion des organisations ? - L’économie de l’autonomie – Les martiens ont-ils disparu ? - La coopĂ©ration dans les institutions et hĂŽpitaux – Entrevue RĂ©sumĂ©s - Le sens des valeurs que l’on porte - Interventions dans l’accompagnement professionnel de couples - Brunch entre amis - Lors des moments difficiles, l’AT nous porte - Counselling de couple avec AT et sexualitĂ© : un couple inĂ©gal ? - On devait toujours parler de tout... discussion pĂšre fille Divers - Éditorial - Prendre soin de nous durant la pandĂ©mie - CĂ©lĂ©brons Fanita English, joyeux 104e anniversaire - Pleine conscience – regards croisĂ©s : retour sur la journĂ©e de l’ASAT-SR - Hommages Ă  Jenni Hine - Entrevue avec Sally CuĂ©nin - Anciens numĂ©ro

    Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

    Get PDF
    A locus at 19p13 is associated with breast cancer (BC) and ovarian cancer (OC) risk. Here we analyse 438 SNPs in this region in 46,451 BC and 15,438 OC cases, 15,252 BRCA1 mutation carriers and 73,444 controls and identify 13 candidate causal SNPs associated with serous OC (P=9.2 × 10-20), ER-negative BC (P=1.1 × 10-13), BRCA1-associated BC (P=7.7 × 10-16) and triple negative BC (P-diff=2 × 10-5). Genotype-gene expression associations are identified for candidate target genes ANKLE1 (P=2 × 10-3) and ABHD8 (P<2 × 10-3). Chromosome conformation capture identifies interactions between four candidate SNPs and ABHD8, and luciferase assays indicate six risk alleles increased transactivation of the ADHD8 promoter. Targeted deletion of a region containing risk SNP rs56069439 in a putative enhancer induces ANKLE1 downregulation; and mRNA stability assays indicate functional effects for an ANKLE1 3â€Č-UTR SNP. Altogether, these data suggest that multiple SNPs at 19p13 regulate ABHD8 and perhaps ANKLE1 expression, and indicate common mechanisms underlying breast and ovarian cancer risk

    Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants with Treatment Resistance in Schizophrenia

    Get PDF
    Importance: About 20% to 30% of people with schizophrenia have psychotic symptoms that do not respond adequately to first-line antipsychotic treatment. This clinical presentation, chronic and highly disabling, is known as treatment-resistant schizophrenia (TRS). The causes of treatment resistance and their relationships with causes underlying schizophrenia are largely unknown. Adequately powered genetic studies of TRS are scarce because of the difficulty in collecting data from well-characterized TRS cohorts. Objective: To examine the genetic architecture of TRS through the reassessment of genetic data from schizophrenia studies and its validation in carefully ascertained clinical samples. Design, Setting, and Participants: Two case-control genome-wide association studies (GWASs) of schizophrenia were performed in which the case samples were defined as individuals with TRS (n = 10501) and individuals with non-TRS (n = 20325). The differences in effect sizes for allelic associations were then determined between both studies, the reasoning being such differences reflect treatment resistance instead of schizophrenia. Genotype data were retrieved from the CLOZUK and Psychiatric Genomics Consortium (PGC) schizophrenia studies. The output was validated using polygenic risk score (PRS) profiling of 2 independent schizophrenia cohorts with TRS and non-TRS: a prevalence sample with 817 individuals (Cardiff Cognition in Schizophrenia [CardiffCOGS]) and an incidence sample with 563 individuals (Genetics Workstream of the Schizophrenia Treatment Resistance and Therapeutic Advances [STRATA-G]). Main Outcomes and Measures: GWAS of treatment resistance in schizophrenia. The results of the GWAS were compared with complex polygenic traits through a genetic correlation approach and were used for PRS analysis on the independent validation cohorts using the same TRS definition. Results: The study included a total of 85490 participants (48635 [56.9%] male) in its GWAS stage and 1380 participants (859 [62.2%] male) in its PRS validation stage. Treatment resistance in schizophrenia emerged as a polygenic trait with detectable heritability (1% to 4%), and several traits related to intelligence and cognition were found to be genetically correlated with it (genetic correlation, 0.41-0.69). PRS analysis in the CardiffCOGS prevalence sample showed a positive association between TRS and a history of taking clozapine (r2 = 2.03%; P =.001), which was replicated in the STRATA-G incidence sample (r2 = 1.09%; P =.04). Conclusions and Relevance: In this GWAS, common genetic variants were differentially associated with TRS, and these associations may have been obscured through the amalgamation of large GWAS samples in previous studies of broadly defined schizophrenia. Findings of this study suggest the validity of meta-analytic approaches for studies on patient outcomes, including treatment resistance
    • 

    corecore